A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy

Supplemental material

• Supplemental file 1 -

  Additional description of model construction and validation, Table S1, and Figures S1 to S8.

  PDF, 1.3M

• Supplemental file 2 -

  Table S2: parameters used in population simulation

  XLSX, 832K

• Supplemental file 3 -

  Table S3: sampled beta for immune-deficient population

  XLSX, 38K